Use of microdialysis to study platinum anticancer agent pharmacokinetics in preclinical models

Journal of Experimental Therapeutics and Oncology

Volumn 2, Issue 3, 2002, Pages 163-173

  Johansen, Mary J ^a   Thapar, Neil ^a   Newman, Robert A ^a   Madden, Timothy ^a  

^a Box 52 ^*  (United States)

Author keywords

Carboplatin; Cisplatin; Drug disposition; Microdialysis; Pharmacokinetics; Tumor

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; PLATINUM DERIVATIVE;

ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; BREAST TUMOR; CANCER CHEMOTHERAPY; DRUG BLOOD LEVEL; DRUG DISPOSITION; DRUG MEGADOSE; DRUG METABOLISM; FEMALE; LIVER TOXICITY; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; CALIBRATION; FISCHER 344 RAT; METHODOLOGY;

ANIMAL; ANTINEOPLASTIC AGENTS; AREA UNDER CURVE; CALIBRATION; CARBOPLATIN; CISPLATIN; FEMALE; MICRODIALYSIS; RATS; RATS, INBRED F344; ANIMALS;

EID: 0035998730     PISSN: 13594117     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1359-4117.2002.01019.x     Document Type: Article

References (48)

1. Push-pull cannulae
2. Use of push-pull cannulae to determine the release of endogenous neurotransmitters in distinct brain areas of anesthetized and freely moving animals
3. The Cortical Cup Technique
4. Model experiments with Gaddum's push-pull cannulas
5. Factors affecting performance of the push-pull cannula in brain
6. The concentration of free amino acids and other electrolytes in cerebrospinal fluid, in vivo dialysate of brain, and blood plasma of the dog
7. Pharmacokinetic and metabolism studies using microdialysis sampling
8. The use of microdialysis in pharmacokinetics and pharmacodynamics
9. Application of microdialysis in pharmacokinetic studies
10. In vivo drug-response measurements in target tissues by microdialysis
11. Microdialysis measurement of glucose in subcutaneous adipose tissue up to three weeks in Type I diabetic patients
12. In-vivo microdialysis study of the distribution of cisplatin into brain tumour tissue after intracarotid infusion in rats with 9L malignant glioma
13. Alterations in methotrexate pharmacokinetics by naproxen in the rat as measured by microdialysis
14. Determination of free extracellular levels of methotrexate by microdialysis in muscle and solid tumor of the rabbit
15. Pharmacokinetics of methotrexate in the extracellular fluid of brain C6-glioma after intravenous infusion in rats
16. Intratumoral differences in methotrexate levels within human osteocarcoma xenografts studied by microdialysis
17. Brain distribution of 6-mercaptopurine is regulated by the efflux transport system in the blood-brain barrier
18. Microdialysis sampling with on-line microbore HPLC for the determination of tirapazamine and its reduced metabolites in rats
19. Modulating antitumor efficacy of bioreductive drugs (mitomycin-C and tirapazamine) with the antivascular agent 5,6-dimethylxanthenone acetic acid
20. Comparative brain tissue distribution of camptothecin and topotecan in the rat
21. Measurement and pharmacokinetics of unbound 20(S)-camptothecin in rat blood and brain by microdialysis coupled to microbore liquid chromatography with fluorescence detection
22. Relationship between tumor extracellular fluid exposure to topotecan and tumor response in human neuroblastoma xenograft and cell lines
23. Microdialysis assessment of 5-fluorouracil release from thermosensitive magnetoliposomes induced by an electromagnetic field in tumor-bearing mice
24. Microdialysis assessment of fibrin glue containing sodium alginate for local delivery of doxorubicin in tumor-bearing rats
25. Can tissue drug concentrations be monitored by microdialysis during or after isolated limb perfusion for melanoma treatment?
26. Effects of P-glycoprotein modulators on etoposide elimination and central nervous system distribution
27. 51Cr-EDTA
28. 5-Fluorouracil kinetics in the interstitial tumor space: Clinical response in breast cancer patients
29. Interstitial methotrexate kinetics in primary breast cancer lesions
30. Delta-aminolevulinic acid in superficial basal cell carcinomas and normal skin a microdialysis and perfusion study
31. Validation of the internal reference technique for microdialysis measurements of interstitial histamine in the rat
32. Microdialysis probe calibration: Gradient and tissue dependent changes in no net flux and reverse dialysis methods
33. Drug distribution studies with microdialysis III: Extracellular concentration of caffeine in adipose tissue in man
34. The pharmacokinetics of high-dose carboplatin in pediatric patients with cancer
35. A program package for simulation and parameter estimation in pharmacokinetic systems
36. Dose-response and duration effects of acute administrations of cocaine and GBR12909 od dopamine synthesis and transporter in the conscious monkey brain: PET studies combined with microdialysis
37. Simultaneous intracerebral microdialysis and positron emission tomography in the detection of ischemia in patients with subarachnoid hemorrhage
38. Validation of urea as an endogenous reference compound for the in vivo calibration of microdialysis probes
39. Validation of and endogenous reference technique for the calibration of microdialysis catheters
40. The comparative pharmacokinetics of carboplatin and cisplatin in mice and rats
41. Double dose-intensive chemotherapy with autologous stem-cell support for breast cancer: No improvement in progression-free survival by the sequence of high-dose melphalan followed by cyclophosphamide, thiotepa, and carboplatin
42. Phase I-II trial of high-dose cyclophosphamide, carboplatin, and autologous bone marrow or peripheral blood stem cell rescue
43. High-dose treatment with carboplatin, etoposide, and ifosfamide followed by autologous stem-cell transplantation in relapsed or refractory germ cell cancer: A phase I/II study
44. High-dose carboplatin, cyclophosphamide, and BCNU with autologous bone marrow support: Excessive hepatic toxicity
45. A phase I clinical and pharmacokinetic study of carboplatin and autologous bone marrow support
46. A phase I study of carboplatin in children with acute leukemia in bone marrow relapse
47. Therapy of refractory/ relapsed acute myeloid leukemia and blast crisis of chronic myeloid leukemia with the combination of cytosine arabinoside, tetrahydrouridine, and carboplatin